William Maughan
Stock Analyst at Clear Street
(4.17)
# 1,722
Out of 5,133 analysts
145
Total ratings
41.7%
Success rate
11.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Reiterated: Buy | $28 | $6.21 | +350.89% | 8 | Aug 18, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $18 | $13.61 | +32.26% | 6 | Aug 7, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $37 | $22.83 | +62.07% | 6 | Aug 5, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | $130 | $91.81 | +41.60% | 3 | Aug 5, 2026 | |
| KRYS Krystal Biotech | Reiterated: Buy | $338 → $311 | $305.23 | +1.89% | 5 | May 4, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | $32 → $31 | $14.15 | +119.08% | 6 | May 1, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $39 → $36 | $3.13 | +1,050.16% | 7 | Apr 28, 2026 | |
| ANNX Annexon | Reiterated: Buy | $17 | $3.92 | +333.67% | 2 | Mar 30, 2026 | |
| CLLS Cellectis | Reiterated: Buy | $9 | $1.18 | +662.71% | 2 | Mar 20, 2026 | |
| IPSC Century Therapeutics | Reiterated: Buy | $6.6 | $1.65 | +300.00% | 10 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.94 | +172.11% | 4 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $181 → $167 | $85.60 | +95.09% | 21 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.6 | $2.17 | +111.98% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $0.3619 | +3,492.15% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $7.64 | +489.01% | 4 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $27 | $20.55 | +31.39% | 11 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $50 | $42.24 | n/a | 4 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $67 | $29.94 | n/a | 4 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $7.56 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $9 | $1.28 | n/a | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $15 | $1.19 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $37.09 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $91 → $106 | $223.37 | n/a | 7 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $3.37 | n/a | 7 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $5 | $23.93 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $253.40 | n/a | 1 | Sep 5, 2022 |
Ocular Therapeutix
Aug 18, 2026
Reiterated: Buy
Price Target: $28
Current: $6.21
Upside: +350.89%
Korro Bio
Aug 7, 2026
Reiterated: Buy
Price Target: $18
Current: $13.61
Upside: +32.26%
Beam Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $37
Current: $22.83
Upside: +62.07%
Dianthus Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $130
Current: $91.81
Upside: +41.60%
Krystal Biotech
May 4, 2026
Reiterated: Buy
Price Target: $338 → $311
Current: $305.23
Upside: +1.89%
Summit Therapeutics
May 1, 2026
Reiterated: Buy
Price Target: $32 → $31
Current: $14.15
Upside: +119.08%
Wave Life Sciences
Apr 28, 2026
Reiterated: Buy
Price Target: $39 → $36
Current: $3.13
Upside: +1,050.16%
Annexon
Mar 30, 2026
Reiterated: Buy
Price Target: $17
Current: $3.92
Upside: +333.67%
Cellectis
Mar 20, 2026
Reiterated: Buy
Price Target: $9
Current: $1.18
Upside: +662.71%
Century Therapeutics
Mar 13, 2026
Reiterated: Buy
Price Target: $6.6
Current: $1.65
Upside: +300.00%
Mar 13, 2026
Reiterated: Buy
Price Target: $8
Current: $2.94
Upside: +172.11%
Mar 11, 2026
Reiterated: Buy
Price Target: $181 → $167
Current: $85.60
Upside: +95.09%
Mar 10, 2026
Reiterated: Buy
Price Target: $4.6
Current: $2.17
Upside: +111.98%
Mar 6, 2026
Reiterated: Buy
Price Target: $13
Current: $0.3619
Upside: +3,492.15%
Mar 6, 2026
Reiterated: Buy
Price Target: $45
Current: $7.64
Upside: +489.01%
Feb 26, 2026
Reiterated: Buy
Price Target: $29 → $27
Current: $20.55
Upside: +31.39%
Nov 11, 2025
Reiterated: Hold
Price Target: $45 → $50
Current: $42.24
Upside: n/a
May 23, 2024
Reiterated: Hold
Price Target: $67
Current: $29.94
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $24
Current: $7.56
Upside: n/a
May 9, 2024
Reiterated: Buy
Price Target: $11 → $9
Current: $1.28
Upside: n/a
May 9, 2024
Reiterated: Buy
Price Target: $16 → $15
Current: $1.19
Upside: n/a
May 9, 2024
Reiterated: Buy
Price Target: $38
Current: $37.09
Upside: n/a
May 3, 2024
Reiterated: Hold
Price Target: $91 → $106
Current: $223.37
Upside: n/a
Feb 20, 2024
Reiterated: Buy
Price Target: $60
Current: $3.37
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $10 → $5
Current: $23.93
Upside: n/a
Sep 5, 2022
Reiterated: Buy
Price Target: n/a
Current: $253.40
Upside: n/a